Fidelity Investments’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36.8M Buy
3,695,431
+3,533,209
+2,178% +$31.6M ﹤0.01% 1541
2025
Q4
$1.37M Sell
162,222
-520
-0.3% -$3.71K ﹤0.01% 2737
2025
Q3
$850K Buy
162,742
+4,563
+3% +$17.4K ﹤0.01% 2847
2025
Q2
$547K Buy
158,179
+115,164
+268% +$343K ﹤0.01% 2929
2025
Q1
$113K Sell
43,015
-53,667
-56% -$210K ﹤0.01% 3503
2024
Q4
$398K Buy
96,682
+6,910
+8% +$37.6K ﹤0.01% 3013
2024
Q3
$636K Buy
89,772
+19,296
+27% +$144K ﹤0.01% 2758
2024
Q2
$460K Sell
70,476
-1,015,613
-94% -$6.94M ﹤0.01% 2765
2024
Q1
$9.01M Sell
1,086,089
-368,854
-25% -$3.6M ﹤0.01% 1902
2023
Q4
$16M Sell
1,454,943
-652,790
-31% -$5.51M ﹤0.01% 1700
2023
Q3
$17.7M Sell
2,107,733
-848,488
-29% -$9.12M ﹤0.01% 1631
2023
Q2
$37.1M Sell
2,956,221
-5,850,770
-66% -$72.8M ﹤0.01% 1381
2023
Q1
$145M Sell
8,806,991
-926,857
-10% -$16.6M 0.01% 851
2022
Q4
$145M Sell
9,733,848
-2,224,364
-19% -$42.6M 0.01% 819
2022
Q3
$268M Sell
11,958,212
-1,376,843
-10% -$30.2M 0.03% 568
2022
Q2
$223M Sell
13,335,055
-2,906,951
-18% -$62.3M 0.02% 647
2022
Q1
$486M Buy
16,242,006
+35,405
+0.2% +$859K 0.04% 450
2021
Q4
$498M Buy
16,206,601
+2,519,797
+18% +$79.6M 0.04% 457
2021
Q3
$432M Buy
13,686,804
+3,324,804
+32% +$112M 0.03% 487
2021
Q2
$379M Buy
10,362,000
+4,533,548
+78% +$149M 0.03% 548
2021
Q1
$201M Buy
5,828,452
+1,066,214
+22% +$46.3M 0.02% 785
2020
Q4
$198M Sell
4,762,238
-53,641
-1% -$2.42M 0.02% 750
2020
Q3
$205M Buy
+4,815,879
New +$184M 0.02% 627

Other funds holding RLAY